These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6118841)

  • 1. Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
    Ross ED; Stewart RM
    Neurology; 1981 Nov; 31(11):1435-9. PubMed ID: 6118841
    [No Abstract]   [Full Text] [Related]  

  • 2. Akinetic mutism responsive to bromocriptine following subdural hematoma evacuation in a patient with hydrocephalus.
    Kim MS; Rhee JJ; Lee SJ; Kwon SJ; Lee CH
    Neurol Med Chir (Tokyo); 2007 Sep; 47(9):419-23. PubMed ID: 17895616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine-responsive akinetic mutism following endoscopy for ventricular neurocysticercosis. Case report and review of the literature.
    Psarros T; Zouros A; Coimbra C
    J Neurosurg; 2003 Aug; 99(2):397-401. PubMed ID: 12924716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Akinetic mutism related to hydrocephalus and cerebellar surgery treated with bromocriptine and ephedrine. A pathophysiological review].
    Mateo-Sierra O; Gutiérrez FA; Fernández-Carballal C; Pinilla D; Mosqueira B; Iza B; Carrillo R
    Neurocirugia (Astur); 2005 Apr; 16(2):134-41; discussion 141. PubMed ID: 15915303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akinetic mutism: pharmacologic probe of the dopaminergic mesencephalofrontal activating system.
    Echiverri HC; Tatum WO; Merens TA; Coker SB
    Pediatr Neurol; 1988; 4(4):228-30. PubMed ID: 3242525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.
    Alexander MP
    Neurorehabil Neural Repair; 2001; 15(2):151-6. PubMed ID: 11811256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akinetic mutism from frontal lobe damage responding to levodopa.
    Combarros O; Infante J; Berciano J
    J Neurol; 2000 Jul; 247(7):568-9. PubMed ID: 10993505
    [No Abstract]   [Full Text] [Related]  

  • 8. Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. Case report.
    Anderson B
    J Neurosurg; 1992 Jan; 76(1):152-5. PubMed ID: 1727155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bromocriptine: could it be the cure for post-surgical akinetic mutism?].
    Arevalo-Saenz A; Pedrosa-Sanchez M; Sola RG
    Rev Neurol; 2017 Jan; 64(2):70-74. PubMed ID: 28075000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
    Watahiki Y; Narita S; Kurahashi K; Tanaka T; Matsunaga M
    No To Shinkei; 1987 Oct; 39(10):977-82. PubMed ID: 3435688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Akinetic mutism in decompensated triventricular hydrocephalus].
    Moser A; Freyberger HJ; Brückmann H; Kömpf D
    Fortschr Neurol Psychiatr; 1995 Jun; 63(6):248-51. PubMed ID: 7635387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of parkinsonism.
    Calne DB; Teychenne PF; Pfeiffer RF
    Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
    [No Abstract]   [Full Text] [Related]  

  • 13. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of a case of akinetic mutism with bromocriptine.
    Stewart JT; Leadon M; Gonzalez-Rothi LJ
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):462-3. PubMed ID: 2136401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of akinetic mutism with bromocriptine].
    Milhaud D; Bernardin G; Roger PM; Deloffre P; Corcelle P; Mattei M
    Presse Med; 1993 Apr; 22(14):688. PubMed ID: 8511118
    [No Abstract]   [Full Text] [Related]  

  • 16. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G; Casacchia M; Zamponi A; Agnoli A
    Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
    [No Abstract]   [Full Text] [Related]  

  • 17. Akinetic mutism and parkinsonism after multiple shunt failure: case report and literature review.
    Rebai RM; Houissa S; Mustapha ME; Azzouni H; Assaggaf S
    J Neurol Surg A Cent Eur Neurosurg; 2012 Sep; 73(5):341-6. PubMed ID: 21445822
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Akinetic mutism and progressive supranuclear palsy-like syndrome after the shunt of an obstructive hydrocephalus. Successful treatment with bromocriptine: 2 cases].
    Aidi S; Elalaoui-Faris M; Benabdeljlil M; Benomar A; Chaoui M; Chkili T
    Rev Neurol (Paris); 2000 Apr; 156(4):380-3. PubMed ID: 10795015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
    Frattola L; Albizzati MG; Spano PF; Trabucchi M
    Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.